Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

How Is The Bioreactors Market Expected To Grow In Terms Of Size?

The bioreactors sector has seen rapid expansion lately. The market size is projected to rise from $9.24 billion in 2024 to $10.61 billion in 2025, with a compound annual growth rate (CAGR) of 14.8%. This substantial growth during the historic timeline can be correlated to factors such as a surge in biopharmaceutical demand, an increase in cell and gene therapy research, a burgeoning interest in personalized medicine, the implementation of single-use bioreactor technology, and the necessity for effective manufacturing procedures.

In the forthcoming years, a swift expansion is predicted in the bioreactors market, with projections estimating it to be worth $18.41 billion in 2029 with a compound annual growth rate (CAGR) of 14.8%. Factors contributing to growth during this period include an upsurge in biotechnology research investment, a higher incidence of chronic illnesses, increased demand for vaccines and therapeutic proteins, heightened regulatory backing for biomanufacturing, and growing utilization of advanced therapies. The major trends anticipated over this forecast period include strides in biotechnology, enhancements in automation and control systems, progress in bioprocess development, improvements in manufacturing efficiency, and a growing necessity for scalable production solutions.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20721&type=smp

What Market Forces Are Contributing To The Growth Of The Bioreactors Market?

The growth of the bioreactors market is anticipated to be boosted by the surging demand for biopharmaceuticals. Biopharmaceuticals refer to therapeutic products obtained from biological sources like proteins, cells, and living entities, having the capacity to manage, treat, and prevent numerous diseases. This escalating demand is a result of advancements in medical studies, personalized medication, and a requirement for cutting-edge treatments promoting enhanced global health outcomes. Bioreactors significantly contribute to biopharmaceuticals by assuring efficient and expandable production of curative products, upholding consistent quality, minimizing production expenses and encouraging the formulation of novel and life-improving drugs. For instance, in May 2024, according to the Pharmaceutical Research and Manufacturers of America, an American trade association, the U.S. biopharmaceutical industry’s total output surpassed $1.65 trillion in 2022, with the direct production amounting to $800 billion and an additional $800 billion via suppliers and different sectors, representing 3.6% of the U.S. economy. Thus, the escalating demand for biopharmaceuticals is propelling the growth of the bioreactors market.

How Is The Bioreactors Market Segmented Across Key Categories?

The bioreactorsmarket covered in this report is segmented –

1) By Type Of Bioprocess: Batch And Fed-Batch; Continuous

2) By Cell: Mammalian Cells; Bacterial Cells; Yeast Cells; Other Cells

3) By Control: Manual; Automated

4) By Usage: Lab Scale Production; Pilot Scale Production; Full Scale Production

5) By End-Use: Research And Development (R&D) Organizations; Biopharmaceutical (Biopharma) Manufacturers; Contract Manufacturing Organizations (CMOS)

Subsegments:

1) By Batch And Fed-Batch: Traditional Batch Bioreactors; Fed-Batch Bioreactors

2) By Continuous: Perfusion Bioreactors; Continuous Stirred Tank Bioreactors (CSTR)

What Key Trends Are Driving Growth In The Bioreactors Market?

Leading firms in the bioreactors market are concentrating on the creation of advanced products such as fixed-bed bioreactors, meant to accommodate the growth of increasingly complex biological cultures. A fixed-bed bioreactor is a kind where biological organisms attach themselves to a solid support, typically made up of porous materials like beads, fibers, or granules. It enables better mass transfer, reduces shear stress, and provides better control of biological processes. For example, in October 2024, Univercells Technologies, a Belgian biotech firm, introduced the Scale-X Nexo bioreactor. This state-of-the-art bioreactor, equipped with a 0.5 m² growth surface, is specifically crafted for optimizing cell culture process development, providing substantial advantages for biopharmaceutical companies and research entities. The Scale-X nexo can smoothly scale up to larger models, conserves media and reagent use, and has the potential to cut operational costs by up to 60% in comparison to conventional entry-level bioreactors. Moreover, it integrates with the Skaia Vision application software, increasing productivity by delivering accurate cell count predictions without needing direct sampling.

Who Are The Major Stakeholders Operating In The Bioreactors Market?

Major companies operating in the bioreactors market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, GE HealthCare Technologies Inc., Cytiva Bioscience Holding Ltd., Sartorius AG, Cellexus Ltd., Getinge AB, Eppendorf AG, ZETA Holding, Pierre Guerin, Broadley-James Corporation, PBS Biotech Inc., TAP Biosystems, Solida Biotech GmBH, BBI-Biotech GmbH, HiTec Zang GmbH, Xiamen Ollital Technology Co. Ltd., Bioengineering AG, Infors AG, Univercells Technologies SA, CerCell A/S, Bailun Biotechnology Co. Ltd., BioNet, Shanghai Ritai Medicine Equipment Project Co. Ltd.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/bioreactors-global-market-report

How Do Regional Dynamics Influence The Bioreactors Market Performance?

North America was the largest region in the bioreactors market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the bioreactors market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=20721&type=smp

Browse Through More Reports Similar to the Global Bioreactors Market 2025, By The Business Research Company

Small Scale Bioreactors Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/small-scale-bioreactors-global-market-report

Feed Yeast Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/feed-yeast-global-market-report

Bioethanol Yeast Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/bioethanol-yeast-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model